<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39456264</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human Enteroviruses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1331</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14101331</ELocationID><Abstract><AbstractText>Enteroviruses have been a historical concern since the identification of polioviruses in humans. Wild polioviruses have almost been eliminated, while multiple species of non-polio enteroviruses and their variants co-circulate annually. To date, at least 116 types have been found in humans and are grouped into the species Enterovirus A-D and Rhinovirus A-C. However, there are few available antiviral drugs, especially with a universal pharmaceutical effect. Here, we demonstrate that peptide P25 from EV-D68 has broad antiviral activity against EV A-D enteroviruses in vitro. P25, derived from the HI loop and β-I sheet of VP1, operates through a conserved hydrophilic motif -R---K-K--K- and the hydrophobic F near the N-terminus. It could prevent viral infection of EV-A71 by competing for the heparan sulfate (HS) receptor, binding and stabilizing virions by suppressing the release of the viral genome. P25 also inhibited the generation of infectious viral particles by reducing viral protein synthesis. The molecular docking revealed that P25 might bind to the pocket opening area, a potential target for broad-spectrum antivirals. Our findings implicate the multiple antiviral effects of peptide P25, including blocking viral binding to the HS receptor, impeding viral genome release, and reducing progeny particles, which could be a novel universal anti-enterovirus drug candidate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaojing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resource and Eco-Environment, Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610064, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Cuiling</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jingdong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jianfang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0009-6719-7155</Identifier><AffiliationInfo><Affiliation>National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022YFC2604100</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="Y">Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">antiviral</Keyword><Keyword MajorTopicYN="N">broad-spectrum</Keyword><Keyword MajorTopicYN="N">human enteroviruses</Keyword><Keyword MajorTopicYN="N">peptide</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39456264</ArticleId><ArticleId IdType="pmc">PMC11506774</ArticleId><ArticleId IdType="doi">10.3390/biom14101331</ArticleId><ArticleId IdType="pii">biom14101331</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu P., Ji W., Li D., Li Z., Chen Y., Dai B., Han S., Chen S., Jin Y., Duan G. Current status of hand-foot-and-mouth disease. J. Biomed. Sci. 2023;30:15. doi: 10.1186/s12929-023-00908-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00908-4</ArticleId><ArticleId IdType="pmc">PMC9951172</ArticleId><ArticleId IdType="pubmed">36829162</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T. Enterovirus 68 among Children with Severe Acute Respiratory Infection, the Philippines. Emerg. Infect. Dis. 2011;17:1430–1435. doi: 10.3201/eid1708.101328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1708.101328</ArticleId><ArticleId IdType="pmc">PMC3381551</ArticleId><ArticleId IdType="pubmed">21801620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia S.-H., Lin J.-J., Chan O.-W., Lin T.-Y. Cardiopulmonary failure in children infected with Enterovirus A71. J. Biomed. Sci. 2020;27:53. doi: 10.1186/s12929-020-00650-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-00650-1</ArticleId><ArticleId IdType="pmc">PMC7161201</ArticleId><ArticleId IdType="pubmed">32299443</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Poliomyelitis.  [(accessed on 11 May 2024)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/poliomyelitis.</Citation></Reference><Reference><Citation>Noisumdaeng P., Puthavathana P. Molecular evolutionary dynamics of enterovirus A71, coxsackievirus A16 and coxsackievirus A6 causing hand, foot and mouth disease in Thailand, 2000–2022. Sci. Rep. 2023;13:17359. doi: 10.1038/s41598-023-44644-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-44644-z</ArticleId><ArticleId IdType="pmc">PMC10576028</ArticleId><ArticleId IdType="pubmed">37833525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., He D., Liu Y., Gong Y., Dong W., Chen Y., Ma S. Complete genome analysis of echovirus 30 strains isolated from hand-foot-and-mouth disease in Yunnan province, China. Virol. J. 2023;20:1–10. doi: 10.1186/s12985-023-02179-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02179-9</ArticleId><ArticleId IdType="pmc">PMC10510139</ArticleId><ArticleId IdType="pubmed">37730633</ArticleId></ArticleIdList></Reference><Reference><Citation>Greninger A.L., Naccache S.N., Messacar K., Clayton A., Yu G., Somasekar S., Federman S., Stryke D., Anderson C., Yagi S., et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): A retrospective cohort study. Lancet Infect. Dis. 2015;15:671–682. doi: 10.1016/S1473-3099(15)70093-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70093-9</ArticleId><ArticleId IdType="pmc">PMC6027625</ArticleId><ArticleId IdType="pubmed">25837569</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspar D.L.D., Klug A. Physical Principles in the Construction of Regular Viruses. Cold Spring Harb. Symp. Quant. Biol. 1962;27:1–24. doi: 10.1101/SQB.1962.027.001.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/SQB.1962.027.001.005</ArticleId><ArticleId IdType="pubmed">14019094</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R.J., Rossmann M.G. Structure determination of enterovirus 71. Acta Crystallogr. Sect. D Struct. Biol. 2012;68:1217–1222. doi: 10.1107/S0907444912025772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444912025772</ArticleId><ArticleId IdType="pmc">PMC3489104</ArticleId><ArticleId IdType="pubmed">22948923</ArticleId></ArticleIdList></Reference><Reference><Citation>Egorova A., Ekins S., Schmidtke M., Makarov V. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses. Eur. J. Med. Chem. 2019;178:606–622. doi: 10.1016/j.ejmech.2019.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.06.008</ArticleId><ArticleId IdType="pmc">PMC8194503</ArticleId><ArticleId IdType="pubmed">31226653</ArticleId></ArticleIdList></Reference><Reference><Citation>Berryman S., Clark S., Kakker N.K., Silk R., Seago J., Wadsworth J., Chamberlain K., Knowles N.J., Jackson T. Positively Charged Residues at the Five-Fold Symmetry Axis of Cell Culture-Adapted Foot-and-Mouth Disease Virus Permit Novel Receptor Interactions. J. Virol. 2013;87:8735–8744. doi: 10.1128/JVI.01138-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01138-13</ArticleId><ArticleId IdType="pmc">PMC3719821</ArticleId><ArticleId IdType="pubmed">23740982</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R., Geraets J.A., Ma Y., Mirabelli C., Flatt J.W., Domanska A., Delang L., Jochmans D., Kumar T.A., Jayaprakash V., et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 2019;17:e3000281. doi: 10.1371/journal.pbio.3000281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000281</ArticleId><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="pubmed">31185007</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Koike S. Cellular receptors for enterovirus A71. J. Biomed. Sci. 2020;27:1–12. doi: 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Sheng J., Fokine A., Meng G., Shin W.-H., Long F., Kuhn R.J., Kihara D., Rossmann M.G. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science. 2015;347:71–74. doi: 10.1126/science.1261962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1261962</ArticleId><ArticleId IdType="pmc">PMC4307789</ArticleId><ArticleId IdType="pubmed">25554786</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M., Pettitt T., Symonds A., Martin J. Identification of the pocket factors in a picornavirus. Arch. Virol. 2003;148:1225–1233. doi: 10.1007/s00705-002-0974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-002-0974-4</ArticleId><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogle J.M. Poliovirus Cell Entry: Common Structural Themes in Viral Cell Entry Pathways. Annu. Rev. Microbiol. 2002;56:677–702. doi: 10.1146/annurev.micro.56.012302.160757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.56.012302.160757</ArticleId><ArticleId IdType="pmc">PMC1500891</ArticleId><ArticleId IdType="pubmed">12142481</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Meijer A., Froeyen M., Zhang L., Thibaut H.J., Baggen J., George S., Vernachio J., van Kuppeveld F.J.M., Leyssen P., et al. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob. Agents Chemother. 2015;59:7782–7785. doi: 10.1128/AAC.01375-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01375-15</ArticleId><ArticleId IdType="pmc">PMC4649165</ArticleId><ArticleId IdType="pubmed">26369972</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K.S., Van Der Avoort H.G., Duizer E., Koopmans M.P. Antivirals against Enteroviruses: A Critical Review from a Public-Health Perspective. Antivir. Ther. 2015;20:121–130. doi: 10.3851/IMP2939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2939</ArticleId><ArticleId IdType="pubmed">25643052</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews T., Salgo M., Greenberg M., Chung J., DeMasi R., Bolognesi D. Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes. Nat. Rev. Drug Discov. 2004;3:215–225. doi: 10.1038/nrd1331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1331</ArticleId><ArticleId IdType="pubmed">15031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Chan Y.F., Sim K.M., Tan E.L., Poh C.L. Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1. PLoS ONE. 2012;7:e34589. doi: 10.1371/journal.pone.0034589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034589</ArticleId><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Ba Q., Wu A., Zhang H., Deng T., Jiang T. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly. FEBS J. 2013;280:1139–1149. doi: 10.1111/febs.12107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12107</ArticleId><ArticleId IdType="pubmed">23279951</ArticleId></ArticleIdList></Reference><Reference><Citation>Memariani H., Memariani M., Moravvej H., Shahidi-Dadras M. Melittin: A venom-derived peptide with promising anti-viral properties. Eur. J. Clin. Microbiol. Infect. Dis. 2019;39:5–17. doi: 10.1007/s10096-019-03674-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-019-03674-0</ArticleId><ArticleId IdType="pmc">PMC7224078</ArticleId><ArticleId IdType="pubmed">31422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Flatt J.W., Domanska A., Seppälä A.L., Butcher S.J. Identification of a conserved virion-stabilizing network inside the interprotomer pocket of enteroviruses. Commun. Biol. 2021;4:1–8. doi: 10.1038/s42003-021-01779-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01779-x</ArticleId><ArticleId IdType="pmc">PMC7910612</ArticleId><ArticleId IdType="pubmed">33637854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Zhu L., Sun Y., Li M., Zhao X., Cui L., Zhang L., Gao G.F., Zhai W., Zhu F., et al. Structures of Echovirus 30 in complex with its receptors inform a rational prediction for enterovirus receptor usage. Nat. Commun. 2020;11:1–10. doi: 10.1038/s41467-020-18251-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18251-9</ArticleId><ArticleId IdType="pmc">PMC7474057</ArticleId><ArticleId IdType="pubmed">32887891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Sun H., Yao X., Li D., Xu L., Li Y., Tian S., Hou T. Comprehensive evaluation of ten docking programs on a diverse set of protein–ligand complexes: The prediction accuracy of sampling power and scoring power. Phys. Chem. Chem. Phys. 2016;18:12964–12975. doi: 10.1039/C6CP01555G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6CP01555G</ArticleId><ArticleId IdType="pubmed">27108770</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Wang L., Pan X. An evaluation of combined strategies for improving the performance of molecular docking. J. Bioinform. Comput. Biol. 2021;19:2150003. doi: 10.1142/S0219720021500037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0219720021500037</ArticleId><ArticleId IdType="pubmed">33641636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasteiger E., Hoogland C., Gattiker A., Wilkins M.R., Appel R.D., Bairoch A. The Proteomics Protocols Handbook. Humana Press; Springer; Totowa, NJ, USA: 2005. Protein identification and analysis tools on the ExPASy server; pp. 571–607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/1-59259-890-0:571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda D.K., Bachmair A., Wünning I., Tobias J.W., Lane W.S., Varshavsky A. Universality and Structure of the N-end Rule. J. Biol. Chem. 1989;264:16700–16712. doi: 10.1016/S0021-9258(19)84762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)84762-2</ArticleId><ArticleId IdType="pubmed">2506181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee H.K., Tan C.W., Yogarajah T., Lee M.H.P., Chai H.J., Hanapi N.A., Yusof S.R., Ong K.C., Lee V.S., Sam I.-C., et al. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathog. 2019;15:e1007863. doi: 10.1371/journal.ppat.1007863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavappa R., Gómez-Yafal A., Hogle J.M. The Poliovirus Empty Capsid Specifically Recognizes the Poliovirus Receptor and Undergoes Some, but Not All, of the Transitions Associated with Cell Entry. J. Virol. 1998;72:7551–7556. doi: 10.1128/JVI.72.9.7551-7556.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.9.7551-7556.1998</ArticleId><ArticleId IdType="pmc">PMC109999</ArticleId><ArticleId IdType="pubmed">9696852</ArticleId></ArticleIdList></Reference><Reference><Citation>E Fricks C., Hogle J.M. Cell-induced conformational change in poliovirus: Externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 1990;64:1934–1945. doi: 10.1128/jvi.64.5.1934-1945.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.64.5.1934-1945.1990</ArticleId><ArticleId IdType="pmc">PMC249347</ArticleId><ArticleId IdType="pubmed">2157861</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K., Ding J., Han J.-F., Zhang Y., Wu X.-Y., He Y.-L., Qin C.-F., Chen R. Human Enterovirus 71 Uncoating Captured at Atomic Resolution. J. Virol. 2014;88:3114–3126. doi: 10.1128/JVI.03029-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03029-13</ArticleId><ArticleId IdType="pmc">PMC3957924</ArticleId><ArticleId IdType="pubmed">24352461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-J., Liu C.-H., Wang J.Y., Lin C.-C., Li Y.-F., Richardson C.D., Lin L.-T. Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding. Emerg. Microbes Infect. 2018;7:1–11. doi: 10.1038/s41426-018-0165-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0165-3</ArticleId><ArticleId IdType="pmc">PMC6156566</ArticleId><ArticleId IdType="pubmed">30254193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi-Ishihara M., Smutná K.F., Alonso F.E., Argilaguet J., Esteve-Codina A., Geiger K., Genescà M., Grau-Expósito J., Duran-Castells C., Rogenmoser S., et al. Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells. Commun. Biol. 2023;6:1–15. doi: 10.1038/s42003-023-04841-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04841-y</ArticleId><ArticleId IdType="pmc">PMC10172343</ArticleId><ArticleId IdType="pubmed">37165099</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez F., Salvador J., Palermo P.M., Mohl J.E., Hanley K.A., Watts D., Llano M. Schlafen 11 Restricts Flavivirus Replication. J. Virol. 2019;93 doi: 10.1128/JVI.00104-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00104-19</ArticleId><ArticleId IdType="pmc">PMC6639263</ArticleId><ArticleId IdType="pubmed">31118262</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonçalves-Carneiro D., Mastrocola E., Lei X., DaSilva J., Chan Y.F., Bieniasz P.D. Rational attenuation of RNA viruses with zinc finger antiviral protein. Nat. Microbiol. 2022;7:1558–1567. doi: 10.1038/s41564-022-01223-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01223-8</ArticleId><ArticleId IdType="pmc">PMC9519448</ArticleId><ArticleId IdType="pubmed">36075961</ArticleId></ArticleIdList></Reference><Reference><Citation>Goonawardane N., Nguyen D., Simmonds P. Association of Zinc Finger Antiviral Protein Binding to Viral Genomic RNA with Attenuation of Replication of Echovirus 7. mSphere. 2021;6 doi: 10.1128/mSphere.01138-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.01138-20</ArticleId><ArticleId IdType="pmc">PMC7845596</ArticleId><ArticleId IdType="pubmed">33408233</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Cao X., Guo H., Wei W. Zinc Influx Restricts Enterovirus D68 Replication. Front. Microbiol. 2021;12 doi: 10.3389/fmicb.2021.748546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.748546</ArticleId><ArticleId IdType="pmc">PMC8548656</ArticleId><ArticleId IdType="pubmed">34721351</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenssen H. Therapeutic Approaches Using Host Defence Peptides to Tackle Herpes Virus Infections. Viruses. 2009;1:939–964. doi: 10.3390/v1030939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v1030939</ArticleId><ArticleId IdType="pmc">PMC3185547</ArticleId><ArticleId IdType="pubmed">21994576</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan T., Liu B., Yao H., Chen X., Yang H., Guo S., Wu B., Li X., Li X., Xun M., et al. Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating. PLoS Pathog. 2024;20:e1011967. doi: 10.1371/journal.ppat.1011967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011967</ArticleId><ArticleId IdType="pmc">PMC10846744</ArticleId><ArticleId IdType="pubmed">38271479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Sam I.-C., Lee V.S., Wong H.V., Chan Y.F. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79–87. doi: 10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Lee H., Hafenstein S., Kataoka C., Wakita T., Bergelson J.M., Shimizu H. Enterovirus 71 Binding to PSGL-1 on Leukocytes: VP1-145 Acts as a Molecular Switch to Control Receptor Interaction. PLoS Pathog. 2013;9:e1003511. doi: 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostina M., Levy H., Filman D.J., Hogle J.M. Poliovirus RNA Is Released from the Capsid near a Twofold Symmetry Axis. J. Virol. 2011;85:776–783. doi: 10.1128/JVI.00531-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00531-10</ArticleId><ArticleId IdType="pmc">PMC3020038</ArticleId><ArticleId IdType="pubmed">20980499</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy H.C., Bostina M., Filman D.J., Hogle J.M. Catching a Virus in the Act of RNA Release: A Novel Poliovirus Uncoating Intermediate Characterized by Cryo-Electron Microscopy. J. Virol. 2010;84:4426–4441. doi: 10.1128/JVI.02393-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02393-09</ArticleId><ArticleId IdType="pmc">PMC2863768</ArticleId><ArticleId IdType="pubmed">20181687</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchta D., Füzik T., Hrebík D., Levdansky Y., Sukeník L., Mukhamedova L., Moravcová J., Vácha R., Plevka P. Enterovirus particles expel capsid pentamers to enable genome release. Nat. Commun. 2019;10:1–9. doi: 10.1038/s41467-019-09132-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09132-x</ArticleId><ArticleId IdType="pmc">PMC6408523</ArticleId><ArticleId IdType="pubmed">30850609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X., Gan J., Sun Q., Li Z., Qin K., Zhang Y., Cao Y., Zhou J. The Structural Framework and Opening Appearance of the VP1-Pocket of Enteroviruses Correlated with Viral Thermostability. Pathogens. 2024;13:711. doi: 10.3390/pathogens13080711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens13080711</ArticleId><ArticleId IdType="pmc">PMC11357065</ArticleId><ArticleId IdType="pubmed">39204311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanem A., Mayer D., Chase G., Tegge W., Frank R., Kochs G., García-Sastre A., Schwemmle M. Peptide-Mediated Interference with Influenza A Virus Polymerase. J. Virol. 2007;81:7801–7804. doi: 10.1128/JVI.00724-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00724-07</ArticleId><ArticleId IdType="pmc">PMC1933368</ArticleId><ArticleId IdType="pubmed">17494067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Li Y., Liu P., Qiao C., Wang X., Wu L., Liu K., Hu Y., Su C., Tan S., et al. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg. Microbes Infect. 2020;9:1238–1241. doi: 10.1080/22221751.2020.1770631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770631</ArticleId><ArticleId IdType="pmc">PMC7448930</ArticleId><ArticleId IdType="pubmed">32482145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Lu G., Qi J., Li Y., Wu Y., Deng Y., Geng H., Li H., Wang Q., Xiao H., et al. Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus. J. Virol. 2013;87:13134–13140. doi: 10.1128/JVI.02433-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02433-13</ArticleId><ArticleId IdType="pmc">PMC3838252</ArticleId><ArticleId IdType="pubmed">24067982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Zheng A., Tang Y., Chai Y., Chen J., Cheng L., Hu Y., Qu J., Lei W., Liu W.J., et al. A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery. Sci. China Life Sci. 2023;66:2201–2213. doi: 10.1007/s11427-023-2410-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-023-2410-5</ArticleId><ArticleId IdType="pubmed">37574525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W., Lang Y., Li T., Zeng Z., Song Y., Wu Y., Li W., Cao Z. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro. 290. 2015;290:23254–23263. doi: 10.1074/jbc.M115.662452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.662452</ArticleId><ArticleId IdType="pmc">PMC4645583</ArticleId><ArticleId IdType="pubmed">26251517</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng G., Montero A., Gastaminza P., Whitten-Bauer C., Wieland S.F., Isogawa M., Fredericksen B., Selvarajah S., Gallay P.A., Ghadiri M.R., et al. A virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA. 2008;105:3088–3093. doi: 10.1073/pnas.0712380105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712380105</ArticleId><ArticleId IdType="pmc">PMC2268589</ArticleId><ArticleId IdType="pubmed">18287023</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Tewari M., Kong R., Zhang R., Ingravallo P., Ralston R. A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry. Antivir. Res. 2010;86:172–179. doi: 10.1016/j.antiviral.2010.02.316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.02.316</ArticleId><ArticleId IdType="pubmed">20156485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>